₹529.90
+₹1.35 (+0.26%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹304 Cr
P/E
26.00
ROE
14.04%
ROCE
19.30%
About BDH Industries Ltd
BDH Industries is engaged in manufacturing of therapeutic formulations covering wide range of Pharmaceuticals segment and Renewableenergy segment.
Founded
1990
CEO
Jayashree Nair
Employees
95
HQ
Mumbai, Maharashtra
About BDH Industries Ltd
BDH Industries is engaged in manufacturing of therapeutic formulations covering wide range of Pharmaceuticals segment and Renewableenergy segment.
Founded:1990
CEO:Jayashree Nair
Employees:95
HQ:Mumbai, Maharashtra
Finished Products
1Pharmaceutical Formulations
₹85.82Cr2Sale of Products
₹64.89Cr3Other Operating Revenue
₹1.06Cr4Export Incentive
₹0.57CrRaw Materials
1Cost of material Consumed
₹97.24Cr2Packing materials
₹4.82CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹610
52W Low
₹280
Volume388
Avg VolumeN/A
Beta0.43
Dividend Yield0.95%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
26.00x
Valuation
P/B Ratio
4.02x
Valuation
EPS
₹20.33
Valuation
Dividend Yield
0.95%
Valuation
ROE
14.04%
Profitability
ROCE
19.30%
Profitability
Revenue by Segment
Contribution & growth by business line
Pharmaceutical
-23.7%98.4%
₹65.47 Cr
Renewable Energy
+12118.8%1.6%
₹1.039 Cr
Geographical Revenue Split
Domestic vs international exposure
Domestic
53.2%
International
46.8%
Within India53.2%
Outside India46.8%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.03x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
3.8%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.